SUMMARY
- OmicsBank raised $2.25M from Redesign Health.
- The funding will support expansion and data network growth.
- OmicsBank provides clinical data infrastructure for healthcare AI.
Follow us
Follow usOmicsBank, a San Francisco, CA-based provider of a clinical data infrastructure platform connecting fragmented hospital data for drug development and healthcare AI, has raised $2.25 million in a seed funding round from Redesign Health.
The company plans to use the capital to expand across the U.S., grow its clinical data network across Asia and the Middle East, expand hospital partnerships, and develop GPU-enabled research environments.
Funding Snapshot
| Metric | Details |
|---|---|
| Fundraise Amount | $2.25 million |
| Funding Stage | Seed |
| Valuation | Not disclosed |
| Company | OmicsBank |
| Sector | HealthTech / Healthcare AI / Clinical Data |
| Headquarters | San Francisco, California, USA |
| Founded | 2025 |
| Lead Investor | Redesign Health |
| Hospitals & Labs | 90+ |
| Patients Covered | 12.5 million |
RECOMMENDED FOR YOU
About OmicsBank
Founded in 2025, by Sumit Sinha and Vijay Goel, OmicsBank develops clinical data infrastructure that connects fragmented healthcare information, and makes it usable for pharmaceutical research, and healthcare AI.
Read More:Georgia-Based Airway Therapeutics Raises $50M in Funding Round
The company's technology is deployed across more than 90 hospitals and diagnostic labs in Asia, where it standardizes and de-identifies multimodal clinical data at the source.
Core offerings include:
- Clinical data infrastructure
- EHR data standardization
- Medical imaging datasets
- Genomic and multi-omics data
- De-identified patient-level datasets
Core Technologies / Products / Services
| Capability/Product | Application/Use Case |
|---|---|
| EHR Data | Supports drug development and real-world evidence |
| Medical Imaging | Provides DICOM datasets for clinical research and AI |
| Pathology Data | Supports cancer research and medical AI |
| Genomic Data | Enables biomarker and genomic research |
| Multi-Omics Data | Supports advanced biomedical research |
Leadership Comments
"Healthcare innovation has become global, and we believe some of the companies with the greatest potential to impact U.S. healthcare will come from exceptional founders solving problems at global scale," said Neil Patel, Head of Ventures at Redesign Health. "With OmicsBank, we underwrote Sumit and Vijay first, and the market second.
"Making medical and pharmaceutical research more representative of emerging-market populations is not only a matter of inclusion. People underrepresented in medical research make up the majority of the world's population. OmicsBank is building the infrastructure to make this data accessible and improve healthcare globally," said Oscar Ramos Moreno, Managing General Partner at Orbit Ventures, who led OmicsBank's pre-seed round in 2025.
Read More:AI Startup Keenable Raises $26M in Seed Funding Round
Recommended Stories for You
Devin Jacobs Jan 24, 2024
Devin Jacobs Feb 25, 2026
Devin Jacobs Nov 30, 2023
Devin Jacobs Apr 4, 2024
Team SR Jun 21, 2024
Devin Jacobs Feb 12, 2024
Trending Stories
Prosperity Partners Receives Investment From Lightyear Capital
Jordan Black Co-founded Senra Systems Lands $65M to Transform Wire Harness Manufacturing
EverLine Appoints Industry Leader and ERCOT President and CEO Pablo Vegas
Runestone Partners With Raidiant To Power Gender-Inclusive
F5 Appoints Cathy Peterman as Chief People Officer
Spectro Cloud Lands $100M to Expand AI Infrastructure Platform
[Funding alert] NYC-based Qortex Secures $10m in Funding
Women’s Healthcare Startup Juno Bio Raises $3.8M in Funding
